For the 6th time on 24-25 February 2016  
*****Corinthia Hotel Budapest, Hungary Login to meeting scheduler demo ENG
PHARM Connect Programme & Speakers

PHARM Connect Congress 2016 will bring you an overview of the Central Eastern European market and the main trends and impacts on the pharmaceutical manufacturing & biotechnology world.

For speaking opportunities please contact Katy Säurich Operations & Production Manager at TEG or Tel: + 36 1 219-5725.


Keynote Presentation: Use of Process Analytical Technology (PAT) in Bioproduction

Balázs Kiss, Head of Operations, Gedeon Richter
  • PAT Approach Applied to Optimize Process Control: Analyze existing process data; Monitor critical attributes in real-time; Control product quality by controlling critical attributes during manufacturing
  • How cell metabolism can be visualised through process?
  • Decrease the necessary batches to complete tech transfer & scale up, hence accelerating development
  • FDA supports the implementation of continuous manufacturing using a science and risk-based approach

Dr. Erik Bogsch, Head of Biotechnology R&D Division, Gedeon Richter

Balázs Kiss, Head of Biotechnological Production Plant, Gedeon Richter 


 Keynote Presentation: 10 Years of Continuous API Production – What we have learned? 

Dr. Peter McDonnell, Global Innovation Strategy & External Partnerships Manager, SANOFI
  • Types of continuous process and process dynamics, batch definition
  • Capital expenditure and OPEX (especially in relation to LEAN)
  • Regulatory experience, PAT controls, comparison with batch processes, QbD, dealing with excursions and practicalities of implementation
  • Special focus on biologics 

Dr. Peter McDonnell, Global Innovation Strategy & External Partnerships Manager, SANOFI & Technical Director, Genzyme


 Case Study Presentation: Single-use Clinical Scale Filling System - From Design to Delivery 

Gèza Lehnert Pall

Merck Sharp and Dohme partnered with Pall Life Sciences and Bausch+Stroebel to design single-use technologies on a filling line to support clinical material production. Key was to use a fully disposable fluid path.

The presentation covers, both:

  • user requirements and complete customer approach as well as 
  • Pall's single-use solutions portfolio for a wide range of final filling applications 

Géza Lehnert, Sales Specialist Single-Use Technology, Pall Life Sciences


Case Study Presentation: Efficient Commercial Manufacturability

  • Quality and Manufacturability by Design
  • Begin with having the end in mind
  • Using risk management to focus efforts
  • A learning organization and applied knowledge management are key to operational efficiency

Dr. Joerg Gampfer, Head of Commercial Manufacturability & Platforms, Baxalta



Case Study Presentation: New Technologies for Product and Supply Chain Security

Geoffroy Bessaud, AVP, Corporate Anti-counterfeiting Coordination Corporate Security, SANOFI
  • Pharmaceutical counterfeit  past and new trends
  • SANOFI commitment to combat counterfeit pharmaceuticals
  • Brand Protection technology

Grzegorz Brzoskowski, Regional Security Director CEE, SANOFI 

Geoffroy BessaudAVP, Corporate Anti-counterfeiting Coordination Corporate Security, SANOFI


Case Study Presentation: Air Humidification and Energy Saving in Pharmaceutical Processes

Valerio Nalini, Application Specialist, Climate Business Unit, CAREL INDUSTRIES
  • Humidity control to enhance productivity
  • Steam vs. adiabatic technologies
  • Evaporative cooling as energy saving opportunity

Valerio Nalini, Application Specialist, Climate Business Unit, CAREL INDUSTRIES 


Case Study Presentation: Energy Efficiency in Automation – A holistic approach

Thomas Schulz, Head of KAM and ISM Biotech and Pharma, FESTO

Energy efficiency in process and factory automation does not depend only on energy efficient products and components. Much more important is the holistic view and the focus on the whole system:

  • The optimized design of a plant or system, the right selection of technologies, combined with intelligent design can increase the energy efficiency of about 15%.
  • Continuous monitoring of energy consumption, inspection and optimization of a plants or system will reduce the energy consumption and increase the energy efficiency. 

Thomas Schulz, Head of Industry & Key-Account Management, BiotechPharma and Cosmetics, FESTO


Case Study Presentation: Mergers & Acquisitions: Current and Future Trends 

István Király, VP, Head of Operations Marburg, Italy, Ankleshwar, GSK Vaccines
  • Setting the scene: Pharmaceutical trends – Mergers & Acquisitions
  • Behind the scene – Integration at up close
  • The 5 elements of an integration
  • Conclusions

István Király, VP, Head of Operations legacy Novartis Sites, GSK Vaccines


Presentation: Next Generation Development of Monoclonal Antibodies

Dr. Daniel Galbraith, Chief Scientific Officer, BioOutsource (Sartorius)
  • BioAnalytics use in Biosimilars
  • Case study using Humira and Remicade
  • Evolving use of different types of bioanalysis
  • The role of specialist CRO support

Dr. Daniel Galbraith, Chief Scientific Officer, Sartorius Stedim BioOutsource

Panel Discussion: Does Efficient Change Control Process Exist?

  • Is there a solution?
  • Are regulators willing to help the industry?


Dr. Zsolt Holló

Head of the Center of

Biological Business Development

and Technology




Dr. Joerg Gampfer

Head of Commercial

Manufacturability & Platforms



Lenka Francišković,

QM, Head of Processes &

Products Quality,


Pharmaceuticals &



Panel Discussion: Experiences and Efforts Fighting Drug Counterfeiting





Dr. Ádám Panker

Public Administration Consultant


Erzsébet Ódor

 Country Security Partner




Dr. Lívia Ilku




Grzegorz Brzoskowski

Regional Security Director CEE




Project Presentations by the Award Winners of the 2nd CEE Pharmaceutical Manufacturing Excellence Award

TEG The Events Group is proud to announce the call for applications for the 2nd CEE Pharmaceutical Manufacturing Excellence Award.

The award has been established to honour, recognise and promote outstanding manufacturing excellence solutions in the rapidly growing region of CEE. Manufacturers as well as solution providers are welcome to apply with their most innovative projects and methods implemented in the region. Applications will be assessed by our highly renowned independent jury and the winners will have the opportunity to present their projects on CEE’s most important pharmaceutical and biotechnology manufacturing summit, PHARM Connect 2016.

Applications should be submitted by 16th of January 2016, and will be assessed by our highly renowned independent jury.

Further information click here


Additional Networking Activities

Site visit to the EGIS Scientific and Technology Centre in Budapest

The congress provides the opportunity to visit the EGIS Scientific and Technology Centre in Budapest limited for 50 delegates only and available on a first come first serve complimentary basis on February 25th at 5:00 p.m.

The Centre was build for the 100th year anniversary of the Company more than 2 years ago. It is presenting pharmaceutical and biotech manufacturing related activities, focusing on professionals in the field. It is a multi-storey building with different manufacturing items on display, a 3D movie, and interactive multimedia computer screens to learn about different pharmaceutical industry related activities from R&D to drug product manufacturing.

Transfer: The bus will leave in front of the Corinthia Grand Hotel Royal on February 25th at 4:00 p.m. and will return after the visit at approximately 7:30 p.m.


Additional Networking Activities

 Site visit to the GlaxoSmithKline Biologicals plant 

The congress provides the opportunity to visit GlaxoSmithKline Biologicals in Gödöllő limited for 50 delegates only and available on a first come first serve complimentary basis on February 23rd at 2:00 p.m.

GlaxoSmithKline Biologicals Kft. is located in Gödöllő and is part of the GlaxoSmithKline Vaccines business branch. At the Gödöllő site GSK is producing, testing and releasing Tetanus and Diphtheria bulk antigens for shipment to other GSK Vaccines sites. About 220 people are involved in the manufacturing of antigens used in vaccines such as Synflorix™, Menitorix™, Hiberix™, and MenHibrix™. The Gödöllő site contributes to the 12% of the annual turn-over of GSK Vaccines.

The visit of the site will provide an opportunity to get more information about the activities of the Gödöllő site, the vaccine manufacturing process and the manufacturing facility of the biotechnology site. The site visit will start with an introduction of the GSK Vaccines business division and the Gödöllő site, including a short movie about the activities which is followed by a site tour including a visit to the manufacturing facility.

Transfer: The bus will leave in front of the Corinthia Grand Hotel Royal on February 23rd at 1:30 p.m. and will return after the visit at approximately 5 p.m.



For speaking opportunities please contact:  Katy Säurich Operations & Production Manager at TEG

Tel: + 36 1 219-5725


Process Automation Sponsor

Pall Life Sciences





Exclusive Legal Partner

EDMF Language Services Kft.

Exclusive Language Service Provider

GSK Vaccines

Exclusive Excursion Partner


Exclusive Excursion Partner

View more

Sample list of sponsors

View more


Lead Association Partner

Hungarian Pharmaceutical Manufacturers Association

View more

Exclusive Hungarian Media Partner

MarketingPirula- PirulaTrend

View more

The Events Group | More Information | Contact Us | BOOK NOW
TheEventsGroup © 2012 | Privacy Policy | Terms Of Use
Design: Nortyx Program: Nortyx Web and Recording studio, Stage technic